Liposarcoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:69078OMIM:613488C49.9
Who is this for?
Show terms as
8Active trials23Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Liposarcoma is a type of cancer that starts in fat cells. It belongs to a group of cancers called soft tissue sarcomas, which grow in the connective tissues of the body — things like fat, muscle, and blood vessels. Liposarcoma most often develops deep inside the body, especially in the thigh, behind the knee, or in the abdomen (belly area). Because it grows in deep tissue, it can become quite large before a person notices it. There are several subtypes of liposarcoma, including well-differentiated, dedifferentiated, myxoid, pleomorphic, and myxoid pleomorphic liposarcoma. Each subtype behaves differently and requires a slightly different treatment approach. Symptoms depend on where the tumor is located. A growing lump or swelling is the most common sign. If the tumor is in the abdomen, it may cause belly pain, a feeling of fullness, or digestive problems. Treatment usually involves surgery to remove the tumor, often combined with radiation therapy. Some subtypes respond to chemotherapy. Newer targeted therapies and immunotherapy options are being studied in clinical trials. The outlook varies widely depending on the subtype, size, and location of the tumor, as well as how early it is caught. With proper treatment at a specialized sarcoma center, many patients can achieve long-term control of the disease.

Key symptoms:

A painless or mildly painful lump or swelling, often deep in the thigh or abdomenA growing mass that may feel firm or softAbdominal pain or discomfortFeeling full quickly when eatingUnexplained weight lossSwelling or heaviness in a limbDifficulty moving a nearby jointNausea or vomiting if the tumor presses on the digestive tractFatigueConstipation or changes in bowel habits if the tumor is in the belly

Clinical phenotype terms (9)— hover any for plain English
Varicose veinsHP:0002619SarcomaHP:0100242
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

9 events
Oct 2024Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Power Life Sciences Inc.

TrialNOT YET RECRUITING
Sep 2024Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Australia and New Zealand Sarcoma Association

TrialRECRUITING
Mar 2022Genomic Risk in Retroperitoneal Sarcoma

Fox Chase Cancer Center

TrialRECRUITING
May 2021APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Ascentage Pharma Group Inc. — PHASE1, PHASE2

TrialRECRUITING
Jan 2021International Prospective Registry on Local Treatment Approaches in MLS

The Netherlands Cancer Institute

TrialRECRUITING
Sep 2020Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Pfizer — PHASE2

TrialACTIVE NOT RECRUITING
Jun 2020Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Memorial Sloan Kettering Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Mar 2018Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

OHSU Knight Cancer Institute — PHASE1

TrialACTIVE NOT RECRUITING
Oct 2017Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Liposarcoma.

8 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

8 recruitingView all trials with filters →
Phase 23 trials
Palbociclib and INCMGA00012 in People With Advanced Liposarcoma
Phase 2
Active
PI: Sandra D'Angelo, MD (Memorial Sloan Kettering Cancer Center) · Sites: Basking Ridge, New Jersey; Middletown, New Jersey +5 more · Age: 1899 yrs
Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery
Phase 2
Active
PI: Christina L Roland (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 1899 yrs
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Phase 2
Active
PI: Pfizer CT.gov Call Center (Pfizer) · Sites: Los Angeles, California; New Haven, Connecticut +36 more · Age: 1899 yrs
Phase 11 trial
Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery
Phase 1
Active
PI: Lara E Davis (OHSU Knight Cancer Institute) · Sites: Portland, Oregon · Age: 1299 yrs
Other3 trials
Genomic Risk in Retroperitoneal Sarcoma
Actively Recruiting
· Sites: Philadelphia, Pennsylvania · Age: 1899 yrs
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Actively Recruiting
PI: Angela Hong (Chris O'Brien Lifehouse) · Sites: Atlanta, Georgia; Columbus, Ohio +7 more · Age: 1899 yrs
International Prospective Registry on Local Treatment Approaches in MLS
Actively Recruiting
PI: Rick Haas, MD/PhD (The Netherlands Cancer Institute) · Sites: Amsterdam · Age: 1899 yrs

Specialists

23 foundView all specialists →
MM
Mark Dickson, MD
Specialist
PI on 3 active trials
AH
Angela Hong
Specialist
PI on 1 active trial12 Liposarcoma publications
CR
Christina L Roland
WESTAMPTON, NJ
Specialist
PI on 2 active trials2 Liposarcoma publications
GM
George D. Demetri, MD
BOSTON, MA
Specialist
PI on 4 active trials1 Liposarcoma publication
HP
Hans Gelderblom, Prof
Specialist
PI on 1 active trial
SM
Sandra D'Angelo, MD
SPRINGFIELD, MO
Specialist
PI on 4 active trials
EN
Elise F Nassif
HOUSTON, TX
Specialist
PI on 1 active trial
DM
David Steffin, MD
HOUSTON, TX
Specialist
PI on 3 active trials
MM
Michael Wagner, MD
Specialist
PI on 1 active trial
MD
Mark Dickson
Specialist
PI on 1 active trial2 Liposarcoma publications
JM
John Livingston, MD
Specialist
PI on 1 active trial
VP
Vishruth Reddy, MD, PhD
LOS ANGELES, CA
Specialist
PI on 1 active trial
LD
Lara E Davis
Specialist
PI on 2 active trials34 Liposarcoma publications
RM
Rick Haas, MD/PhD
Specialist
PI on 2 active trials
MM
Michael Heinrich, MD
Specialist
PI on 1 active trial
KP
KANTOR Guy, PU-PH
Specialist
PI on 1 active trial
BS
Brian L Samuels
Specialist
PI on 1 active trial
BI
Benjamin Izar
NEW YORK, NY
Specialist
PI on 2 active trials
NA
Nilofer Azad
BALTIMORE, MD
Specialist
PI on 2 active trials
CY
Cassian Yee
HOUSTON, TX
Specialist
PI on 1 active trial
WC
Warren Chow
TEMPLE CITY, CA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Liposarcoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open LiposarcomaForum →

No community posts yet. Be the first to share your experience with Liposarcoma.

Start the conversation →

Latest news about Liposarcoma

Disease timeline:

New recruiting trial: APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

A new clinical trial is recruiting patients for Liposarcoma

New recruiting trial: Genomic Risk in Retroperitoneal Sarcoma

A new clinical trial is recruiting patients for Liposarcoma

New recruiting trial: Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

A new clinical trial is recruiting patients for Liposarcoma

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific subtype of liposarcoma do I have, and how does that affect my treatment options and prognosis?,Should my tumor tissue be tested for MDM2 amplification or other genetic markers, and what would those results mean for my treatment?,Is surgery possible, and what are the chances of getting clear margins?,Should I be treated at a specialized sarcoma center, and can you refer me to one?,Are there clinical trials I might be eligible for, especially for targeted therapies?,How often will I need follow-up imaging, and what are the signs that the cancer has come back?,What support services — such as physical therapy, nutrition counseling, or mental health support — are available to me during and after treatment?

Common questions about Liposarcoma

What is Liposarcoma?

Liposarcoma is a type of cancer that starts in fat cells. It belongs to a group of cancers called soft tissue sarcomas, which grow in the connective tissues of the body — things like fat, muscle, and blood vessels. Liposarcoma most often develops deep inside the body, especially in the thigh, behind the knee, or in the abdomen (belly area). Because it grows in deep tissue, it can become quite large before a person notices it. There are several subtypes of liposarcoma, including well-differentiated, dedifferentiated, myxoid, pleomorphic, and myxoid pleomorphic liposarcoma. Each subtype behaves

How is Liposarcoma inherited?

Liposarcoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Liposarcoma typically begin?

Typical onset of Liposarcoma is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Liposarcoma?

Yes — 8 recruiting clinical trials are currently listed for Liposarcoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Liposarcoma?

23 specialists and care centers treating Liposarcoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.